Avaí Bio, Inc. (AVAI)
OTCMKTS · Delayed Price · Currency is USD
0.1220
-0.0030 (-2.40%)
Aug 17, 2026, 11:13 AM EST
Avaí Bio Income Statement
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| - | - | - | - | 0.28 | 0.92 | |
Revenue Growth | - | - | - | - | -70.01% | -24.12% |
Cost of Revenue | - | - | - | - | 0.32 | 0.71 |
Gross Profit | - | - | - | - | -0.04 | 0.21 |
Selling, General & Admin | 1.37 | 1.44 | 1.46 | 2.04 | 0.3 | 0.51 |
Research & Development | 0.02 | 0.02 | - | - | - | - |
Amortization of Goodwill & Intangibles | 0.02 | 0.03 | 0.07 | - | - | - |
Other Operating Expenses | - | - | - | 0.01 | -0.01 | -0.22 |
Operating Expenses | 1.41 | 1.48 | 1.53 | 2.13 | 0.31 | 0.34 |
Operating Income | -1.41 | -1.48 | -1.53 | -2.13 | -0.35 | -0.13 |
Interest Expense | -0.33 | -0.27 | -0.06 | - | - | - |
Other Non Operating Income (Expenses) | -0.05 | - | - | - | 0 | - |
EBT Excluding Unusual Items | -1.79 | -1.75 | -1.59 | -2.13 | -0.35 | -0.13 |
Other Unusual Items | - | - | 0.45 | - | - | - |
Pretax Income | -1.81 | -1.75 | -1.14 | -2.13 | -0.35 | -0.13 |
Net Income | -1.81 | -1.75 | -1.14 | -2.13 | -0.35 | -0.13 |
Net Income to Common | -1.81 | -1.75 | -1.14 | -2.13 | -0.35 | -0.13 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 142 | 138 | 128 | 87 | 39 | 26 |
Shares Outstanding (Diluted) | 142 | 138 | 128 | 87 | 39 | 26 |
Shares Change | 6.39% | 7.67% | 48.09% | 124.74% | 46.31% | 0.13% |
EPS (Basic) | -0.01 | -0.01 | -0.01 | -0.02 | -0.01 | -0.00 |
EPS (Diluted) | -0.01 | -0.01 | -0.01 | -0.02 | -0.01 | -0.00 |
EPS Growth | - | - | - | - | - | - |
Free Cash Flow | -1.18 | -1.01 | -1.16 | -1.32 | -0.05 | -0.54 |
Free Cash Flow Per Share | -0.01 | -0.01 | -0.01 | -0.01 | -0.00 | -0.02 |
Gross Margin | - | - | - | - | -14.64% | 22.88% |
Operating Margin | - | - | - | - | -126.28% | -13.73% |
Profit Margin | - | - | - | - | -126.28% | -13.73% |
Free Cash Flow Margin | - | - | - | - | -19.71% | -58.07% |
EBITDA | -1.39 | -1.45 | -1.46 | -2.05 | -0.33 | -0.09 |
EBITDA Margin | - | - | - | - | -117.80% | -9.77% |
D&A For EBITDA | 0.02 | 0.03 | 0.07 | 0.08 | 0.02 | 0.04 |
EBIT | -1.41 | -1.48 | -1.53 | -2.13 | -0.35 | -0.13 |
EBIT Margin | - | - | - | - | -126.28% | -13.73% |
Revenue as Reported | - | - | - | - | 0.28 | 0.92 |